Key facts
| Price (PPV) | 99.40 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | acide ibandronique |
| Class | Drugs for treatment of bone diseases |
| ATC code | M05BA06 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite unitaire |
| Hospital price | 62.10 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’ostéoporose post-ménopausique chez la femme à risque augmenté de fracture. Une réduction du risque de fractures vertébrales a été démontrée, l’efficacité sur les fractures du col du fémur n’a pas été établie.
Find an open pharmacy
On-call pharmacies near you
About Bonfix 150 mg
Bonfix 150 mg belongs to the drugs for treatment of bone diseases therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Bonfix 150 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Bonfix 150 mg
Answers to common questions from Moroccan patients about this drug.